Miso is right - he advocates fixing fundamental problems rather than milking money from other shareholders. That's what a lot of people on hotcopper try to do - buy low & milk money from less knowledgeable shareholders- I rate Biota but my eyes are open. Miso, I feel Autoflight has recognised fundamnetal problems, but his approach maybe different from yours.
The Hunter Hall video is excellent, but look at the body language when there is talk of the power of the RELENZA brand. There lies the problem, the RELENZA brand is weak, and Hunter Hall knows it. Someone needs to take the lead on developing the RELENZA brand - unfortunately history has shown that it won't be Biota management nor GSK. Hopefully Hunter Hall can take up the challenge - as I sais before - I am impressed by the video.
BTA Price at posting:
$1.28 Sentiment: Buy Disclosure: Held